Shield-1 (Shld1): Mechanism of Action

Shield-1 (Shld1) MOA:Targeting FKBP12/Ubiquitin-Proteasome Pathway for CAR-T Cell Therapy and Immunotherapy

🎯 check Shield-1 (Shld1) product page

Shield-1 (Shld1) is a synthetic, reversible FKBP destabilization domain stabilizer. It affects NF-κB and DNA damage signaling pathways, by binding to DD-tagged fusion proteins and preventing their degradation, to promote precise control of targeted protein expression and cellular functions.

Primary Applications and Mechanism of Action